Okomera Partners with Servier to Advance Cancer Drug Development Using Tumour Modelling Technology

Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, softwa...

October 22, 2026 | Thursday | News
FDA Approves GSK and Ionis’ Hibsago for Chronic Hepatitis B Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for t...

October 22, 2026 | Thursday | News
Anteris Technologies Secures German Regulatory Clearance for DurAVR Heart Valve Trial

Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced that it has received full regulato...

October 21, 2026 | Wednesday | News
Lundbeck Advances Lu AF28996 into Phase II Trial for Advanced Parkinson’s Disease

Managing motor fluctuations and dyskinesia remains a significant challenge for people living with advanced Parkinson's disease, despite advances in existin...

October 20, 2026 | Tuesday | Interview
Rhythm Pharmaceuticals Launches IMCIVREE in Japan for Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living ...

October 15, 2026 | Thursday | News
InnoCare Wins China Approval for Phase 3 Mesutoclax Study in MZL

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that...

October 14, 2026 | Wednesday | News
FDA Grants Fast Track Status to Leads Biolabs’ Opamtistomig in Biliary Tract Cancer

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that the U.S. Food and Drug Admin...

October 13, 2026 | Tuesday | News
Axplora Advances Axotecan to Establish European Exatecan Supply for ADC Developers

Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with...

October 08, 2026 | Thursday | News
Biomapas Acquires Pinnaxis to Expand Drug Safety Technology and Consulting Capabilities

Biomapas, a leading integrated life sciences services provider, announces the acquisition of Pinnaxis, a global pharmacovigilance technology and consulting...

October 08, 2026 | Thursday | News
Ofichem to Acquire Kinentia Biosciences to Expand Drug Substance CDMO Business in US

Ofichem has signed an agreement to acquire Kinentia Biosciences, a Drug Substance CDMO based in Rensselaer, New York. Completion of the transaction remains...

October 08, 2026 | Thursday | News
DaltonTx Launches Advanced Antibody Discovery Capabilities for AI-Driven Drug Development

New capabilities enable researchers to analyse, characterise and prioritise antibody candidates at scale  Integrated AI models and workflows suppor...

October 02, 2026 | Friday | News
Ensera Launches Alliance Network to Streamline Drug-Device Combination Product Commercialisation

Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together l...

October 02, 2026 | Friday | News
Genentech’s Fenebrutinib Receives FDA Priority Review for Relapsing and Progressive Multiple Sclerosis

Fenebrutinib cut relapses by 51% and 58% vs teriflunomide in Phase III RMS trials (FENhance 1 & 2) while showing a consistent, positive trend in dela...

October 01, 2026 | Thursday | News
Innovent Reports Phase 1 Data for IBI3003 Trispecific Antibody in Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercializat...

September 30, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close